Literature DB >> 3794614

Family physician recognition and treatment of severe hypercholesterolemia.

D J Madlon-Kay.   

Abstract

Family physician recognition and treatment of severe hypercholesterolemia was determined in a residency program by chart audit. Two hundred seventeen clinic patients were identified as having cholesterol levels greater than 260 mg/dL. In only 47 percent of cases was the abnormality noted in the clinic record. Sixty-nine percent of the patients received no treatment, 29 percent were treated with diet, and 7 percent with drug therapy. Family physicians were much more likely to recognize and somewhat more likely to treat hypercholesterolemia if the level was greater than 305 mg/dL and, therefore, marked as abnormal on the laboratory report. An educational program to improve physician management of hypercholesterolemia had no significant effect. Although further education using different teaching approaches may be helpful, the use of optimal rather than statistically "normal" cholesterol ranges by the laboratory may be a better way to improve physician performance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3794614

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  5 in total

1.  Resident recognition and treatment of hypercholesterolaemic patients.

Authors:  R M Fincher; L Q Rogers; L M Herring; L A Lewis; L D Nance
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

2.  Primary care clinician compliance with cholesterol treatment guidelines.

Authors:  J M Schectman; E G Elinsky; B A Bartman
Journal:  J Gen Intern Med       Date:  1991 Mar-Apr       Impact factor: 5.128

3.  Dietary counseling of hypercholesterolemic patients by internal medicine residents.

Authors:  M A Levine; R S Grossman; P M Darden; S M Jackson; J G Peden; A S Ammerman; M L Levin; R D Layne; L Q Rogers; C B Seelig
Journal:  J Gen Intern Med       Date:  1992 Sep-Oct       Impact factor: 5.128

4.  Detection and treatment of hypercholesterolemia in a biethnic community, 1979-1985.

Authors:  J A Pugh; M P Stern; S M Haffner; H P Hazuda; J Patterson
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

5.  National trends in statin use by coronary heart disease risk category.

Authors:  Jun Ma; Niraj L Sehgal; John Z Ayanian; Randall S Stafford
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.